Please use this identifier to cite or link to this item: https://repositorio.unifesp.br/handle/11600/31520
Title: Inhibition of hypothalamic Foxo1 expression reduced food intake in diet-induced obesity rats
Authors: Ropelle, Eduardo R.
Pauli, Jose R. [UNIFESP]
Prada, Patricia
Cintra, Dennys E.
Rocha, Guilherme Z.
Moraes, Juliana C.
Frederico, Marisa J. S.
Luz, Gabrielle da
Pinho, Ricardo A.
Carvalheira, Jose B. C.
Velloso, Licio A.
Saad, Mario A.
De Souza, Claudio T.
Univ Extremo Catarinense
Universidade Estadual de Campinas (UNICAMP)
Universidade Federal de São Paulo (UNIFESP)
Issue Date: 15-May-2009
Publisher: Wiley-Blackwell
Citation: Journal of Physiology-london. Malden: Wiley-Blackwell Publishing, Inc, v. 587, n. 10, p. 2341-2351, 2009.
Abstract: Insulin signalling in the hypothalamus plays a role in maintaining body weight. the forkhead transcription factor Foxo1 is an important mediator of insulin signalling in the hypothalamus. Foxo1 stimulates the transcription of the orexigenic neuropeptide Y and Agouti-related protein through the phosphatidylinositol-3-kinase/Akt signalling pathway, but the role of hypothalamic Foxo1 in insulin resistance and obesity remains unclear. Here, we identify that a high-fat diet impaired insulin-induced hypothalamic Foxo1 phosphorylation and degradation, increasing the nuclear Foxo1 activity and hyperphagic response in rats. Thus, we investigated the effects of the intracerebroventricular (i.c.v.) microinfusion of Foxo1-antisense oligonucleotide (Foxo1-ASO) and evaluated the food consumption and weight gain in normal and diet-induced obese (DIO) rats. Three days of Foxo1-ASO microinfusion reduced the hypothalamic Foxo1 expression by about 85%. i.c.v. infusion of Foxo1-ASO reduced the cumulative food intake (21%), body weight change (28%), epididymal fat pad weight (22%) and fasting serum insulin levels (19%) and increased the insulin sensitivity (34%) in DIO but not in control animals. Collectively, these data showed that the Foxo1-ASO treatment blocked the orexigenic effects of Foxo1 and prevented the hyperphagic response in obese rats. Thus, pharmacological manipulation of Foxo1 may be used to prevent or treat obesity.
URI: http://repositorio.unifesp.br/handle/11600/31520
ISSN: 0022-3751
Other Identifiers: http://dx.doi.org/10.1113/jphysiol.2009.170050
Appears in Collections:Artigo

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.